Table 4.

Univariate analysis and multivariate predictors for SICH

Variable	No SICH (n = 205)	Yes SICH (n = 22)	p-value	p-value (Wald’s test)	OR (95% CI)
Age-years, mean (SD)	65.7 (13.2)	68.0 (10.6)	0.366
Gender, n (%)
Male Female	140 (90.9) 65 (89.0)	14 (9.1) 8 (11.0)	0.639
Baseline NIHSS, median (IQR)	16.0 (11.0–20.0)	18.0 (10.0–20.0)	0.795
IV-FL, n (%)
Yes No	130 (89.0) 75 (92.6)	16 (11.0) 6 (7.4)	0.486
Baseline ASPECTS, median (IQR)	9.0 (8.0–10.0)	8.0 (7.3–9.0)	0.026	< 0.0001	0.60 (0.51–0.70)
Intracranial Lesion site, n (%)
ICA ICA T-type M1 M2 or distal Hemodynamic TLs	13 (86.7) 37 (88.1) 83 (85.6) 40 (97.6) 32 (100)	2 (13.3) 5 (11.9) 14 (14.4) 1 (2.4) 0 (0)	0.035
Extracranial Lesion
1. Etiology, n (%)
Plaque Dissection	153 (89.0) 52 (94.5)	19 (11.0) 3 (5.5)	0.299
2. Type, n (%)
Occlusion Subocclusion or Stenosis	117 (90.0) 88 (90.7)	13 (10.0) 9 (9.3)	1
Collateral Flow, n (%)
Good Moderate Poor	93 (93.9) 68 (90.7) 44 (83.0)	6 (6.1) 7 (9.3) 9 (17.0)	0.113
Anesthesia, n (%)
General Anesthesia Conscious Sedation	94 (90.4) 111 (90.2)	10 (9.6) 12 (9.8)	1
Intracranial Thrombectomy, n (%)
TA SCoT	98 (90.7) 57 (82.6)	10 (9.3) 12 (17.4)	0.160
eCAS, n (%)
Yes No	112 (84.8) 93 (97.9)	20 (15.2) 2 (2.1)	0.001	0.002	8.18 (2.15-31.12)
Antiplatelet Therapy
1. All, n (%)
Yes No	113 (86.9)	17 (13.1)	0.067
2. Class, n (%)
ASA P2Y12 Inhibitors GpIIb/IIIa Inhibitors	54 (85.7) 8 (100) 51 (86.4)	9 (14.3) 0 (0) 8 (13.6)	0.736
Order of treatment, n (%)
Anterograde approach Retrograde approach	59 (88.1) 53 (81.5)	8 (11.9) 12 (18.5)	0.338
Timing-minutes, mean (SD)
OTG GTR	250.3 (112.7) 74.4 (43.1)	281.8 (160.3) 89.8 (43.8)	0.379 0.131
Complications, n (%)
Yes No	28 (73.7) 177 (93.7)	10 (26.3) 12 (6.3)	0.0008	< 0.0001	6.27 (2.24–17.54)
mTICI, n (%)
2b-3 0-2a	158 (90.3) 47 (90.4)	17 (9.7) 5 (9.6)	1
Extracranial ICA Recanalization, n (%)
Yes No	176 (89.3) 29 (96.7)	21 (10.7) 1 (3.3)	0.324